Search
Dr Christopher Charles Herbert

Dr Christopher Charles Herbert

Clinical oncology 04703943

 

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Brain/CNS
  • Skin

Offers

  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

Dr Chris Herbert qualified in medicine at Birmingham University in 2000. He trained in Clinical Oncology in Bristol and completed his oncology training as a clinical research fellow at the British Columbia Cancer Agency in Vancouver, Canada, where he specialised in stereotactic radiosurgery and the treatment of benign and malignant adult brain tumours.

Appointed as consultant Clinical Oncologist in Bristol in 2011, he has an interest in the treatment melanoma and brain tumours, both primary and secondary. He has expertise in the treatment of metastatic and high risk melanoma with immunotherapy and targeted treatments. He has trained in technical radiotherapy, specialising in the treatment of adult brain tumours, including stereotactic radiosurgery and proton therapy. He has published work on stereotactic radiosurgery and external beam radiotherapy in international, peer reviewed journals.

Areas of interest

Melanoma, primary brain tumours and brain metastases

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0005

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (5-50)

    GenesisCare, Bristol (5-50) Spire Bristol Hospital (1-5)

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    GenesisCare, Bristol (5-50)

  • X0002

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (5-50)

    GenesisCare, Bristol (1-5)

  • A0380

    Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (5-50)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

    GenesisCare, Bristol (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.